| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |